Details for New Drug Application (NDA): 018245
✉ Email this page to a colleague
NDA 018245 describes SYNTOCINON, which is a drug marketed by Novartis and Rtrx and is included in two NDAs. Additional details are available on the SYNTOCINON profile page.
The generic ingredient in SYNTOCINON is oxytocin. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxytocin profile page.
The generic ingredient in SYNTOCINON is oxytocin. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxytocin profile page.
Summary for 018245
| Tradename: | SYNTOCINON |
| Applicant: | Novartis |
| Ingredient: | oxytocin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018245
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10USP UNITS/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
